obstructive pulmonary disease Flashcards
(44 cards)
increased secretions and increased spasms
asthma
increased secretions
bronchitis
loss of surrounding supporting tissue
emphysema
chronic inflammation of the airway and variable airflow obstruction; presence of intermittent symptoms
asthma
what is the cause of asthma?
immune-mediated airway inflammation caused by exposure to an allergen or an irritant
what are some symptoms of asthma
-sob
-wheezing
-coughing
-chest tightness
-feeling of breathlessness
what are some signs of a severe asthma episode
-wheezing
-orothpnea
-tachypnea
-tachycardia
-use of accessory muscles
=qgitation
-intercostal retractions
what are some common allergens
-dust mites
-smoke
-foods
-animal dander
-excersie
-pollution
true/false: type 2 inflammation involves innate and adaptive immune systems
true
type 2 inflammation: _____ induces B-cell isotope (antibody) switching to production of IgE
IL-4
type 2 inflammation: IgE, through its binding to _______ and ______ results in environmental sensitivity to allergens
basophils and mast cells
type 2 inflammation: what are the products from the cross linkage of IgE on the surface of basophils and mast cells
type II cytokines and direct activators of smooth muscle contraction and edema
type 2 inflammation: ____ has a critical role in regulating eosinophils. it controls formation, recruitment and survival of these cells
IL-5
type 2 inflammation: _____ induces airway hyperresponsivemess, mucus hyper secretion, and goblet cell metaplasia.
IL-13
type 2 inflammation: ____ can produce IL-5 and IL-13. they can be activated by epithelial cytokines known as alarming, which are produced in response to “nonallergic” epithelial exposures such as irritants, pollutants, oxidative agents, fungi or viruses.
type 2 innate lymphoid cells (ILC2)
non-type 2 inflammation: true/false: non-type 2 processes can exist either in combination which type 2 inflammation or without type 2 inflammation
true
non-type 2 inflammation: which type of inflammation is more commonly seen in severe asthma, that has not responded to the common anti-inflammatory therapies such as corticosteroids, that usually suppress type 2 inflammation
neutrophilic inflammation
these 3 cytokines are the major cytokines associated with type 2 inflammation, and have been targeted successfully in asthma therapies
Il-4,5, and 13
true/false: thymic stromal lymphopoetin (TSLP), IL-25 and IL-33 also play a role in the signalling cascade and have been targeted successfully in asthma therapies
false - actively being studied as targets for tx of asthma
these cytokines have been implicated in non-type 2 inflammation
IL-6, IL-17, TNF alpha, IL-1beta and IL-8
what are pre-disposing (risk) factors of asthma
- genetics *mutation on chromosome 17q21
- family history of asthma
- positive skin test to an allergen
- tobacco (second hand and maternal smoke)
- air pollution
- diets (vitamin D deficiency)
- obesity
- medications
- occupational exposures
this type of inflammation is eosinophilic predominant and an IgE response is common.
clinical manifestations include: elevated IgE levels, eczema, allergic rhinitis, positive fam history of allergen and attacks associated with seasonal, environmental or occupational exposure
type 2 inflammation
know the IgaE dependant pathway of the pathogenesis of asthma
an allergen is present -> mast cells and eosinophils are activated -> prostaglandins, leukotrines, interleukins and cytokines are released -> there is acute/chronic inflammation -> bronchoconstriciton, mucus and edema production, airway hyperresponsiveness
know the IgE independent pathway of the pathogenesis of asthma
cold/exercise, osmotic stimuli, irritant exposure -> mast cells and eosinophils activated -> prostaglandins, leukotrienes, interleukins and cytokines released -> acute/chronic inflammation -> bronchoconstriction, mucus & edema production and airway hyperresponsiveness